Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor TherapyJames N. Ingle, Liewei Wang, Fang Xie et al.|Cancer Research|2016Cited by 78
Supplementary Material from Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor TherapyJames N. Ingle, Liewei Wang, Fang Xie et al.|Unknown|2023Cited by 0
Supplementary Figure S4 from Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor TherapyJames N. Ingle, Liewei Wang, Poulami Barman et al.|Unknown|2023Cited by 0
Supplementary Figure S6 from Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor TherapyJames N. Ingle, Liewei Wang, Fang Xie et al.|Unknown|2023Cited by 0
Supplementary Figure S3 from Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor TherapyJames N. Ingle, Liewei Wang, Fang Xie et al.|Unknown|2023Cited by 0